Kurt Von Emster, Director at CRISPR Therapeutics AG (CRSP), sold 1,291,100 shares at $53.36 ($70.2M) on 2018-05-11, disclosed to the SEC on 2018-05-15.
Open-market sale of $70.2M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.73 | 8,633 | $447K | 0.6% |
| 2 | $51.73 | 8,633 | $447K | 0.6% |
| 3 | $52.46 | 127,890 | $6.7M | 9.6% |
| 4 | $52.46 | 127,890 | $6.7M | 9.6% |
| 5 | $53.36 | 113,477 | $6.1M | 8.6% |
| 6 | $53.36 | 113,477 |
| $6.1M |
| 8.6% |
| 7 | $52.20 | 8,900 | $465K | 0.7% |
| 8 | $52.93 | 20,881 | $1.1M | 1.6% |
| 9 | $52.93 | 20,881 | $1.1M | 1.6% |
| 10 | $53.86 | 53,927 | $2.9M | 4.1% |
| 11 | $53.86 | 53,927 | $2.9M | 4.1% |
| 12 | $54.99 | 126,901 | $7.0M | 9.9% |
| 13 | $54.99 | 126,901 | $7.0M | 9.9% |
| 14 | $55.72 | 73,144 | $4.1M | 5.8% |
| 15 | $55.72 | 73,144 | $4.1M | 5.8% |
| 16 | $56.90 | 116,247 | $6.6M | 9.4% |
| 17 | $56.90 | 116,247 | $6.6M | 9.4% |
| Total | $54.41 avg | 1,291,100 | $70.2M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |